Richard Mast

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Correction: Combined radiomics, PI-RADS, and clinical model improve significant prostate cancer prediction and guide biopsy decision.

Correction: Combined radiomics, PI-RADS, and clinical model improve significant prostate cancer prediction and guide biopsy decision.

Journal: Insights into imaging

Published: June 02, 2026

Poorly differentiated neuroendocrine transformation from metastatic upper tract urothelial carcinoma.

Poorly differentiated neuroendocrine transformation from metastatic upper tract urothelial carcinoma.

Journal: BMJ case reports

Published: February 12, 2026

Combined radiomics, PI-RADS, and clinical model improve significant prostate cancer prediction and guide biopsy decision.

Combined radiomics, PI-RADS, and clinical model improve significant prostate cancer prediction and guide biopsy decision.

Journal: Insights into imaging

Published: December 04, 2025

Combined neuroendocrine carcinoma of the penis: clinical, pathological and therapeutic insights.

Combined neuroendocrine carcinoma of the penis: clinical, pathological and therapeutic insights.

Journal: BMJ case reports

Published: July 01, 2025

Histology-informed microstructural diffusion simulations for MRI cancer characterisation-the Histo-μSim framework.

Histology-informed microstructural diffusion simulations for MRI cancer characterisation-the Histo-μSim framework.

Journal: Communications biology

Published: January 30, 2025

Clinically feasible liver tumour cell size measurement through histology-informed in vivo diffusion MRI.

Clinically feasible liver tumour cell size measurement through histology-informed in vivo diffusion MRI.

Journal: Communications medicine

Published: December 05, 2024

Homologous recombination repair status in metastatic prostate cancer by next-generation sequencing and functional immunofluorescence.

Homologous recombination repair status in metastatic prostate cancer by next-generation sequencing and functional immunofluorescence.

Journal: Cell reports. Medicine

Published: July 21, 2024

The Role of Radiomics in the Prediction of Clinically Significant Prostate Cancer in the PI-RADS v2 and v2.1 Era: A Systematic Review.

The Role of Radiomics in the Prediction of Clinically Significant Prostate Cancer in the PI-RADS v2 and v2.1 Era: A Systematic Review.

Journal: Cancers

Published: July 18, 2024

Enhancing Tumor Microstructural Quantification With Machine Learning and Diffusion-Relaxation MRI.

Enhancing Tumor Microstructural Quantification With Machine Learning and Diffusion-Relaxation MRI.

Journal: Journal of magnetic resonance imaging : JMRI

Published: December 22, 2023

Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial.

Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial.

Journal: European urology

Published: December 20, 2023

Circulating tumor extracellular vesicles to monitor metastatic prostate cancer genomics and transcriptomic evolution.

Circulating tumor extracellular vesicles to monitor metastatic prostate cancer genomics and transcriptomic evolution.

Journal: Cancer cell

Published: August 24, 2023

Radioguided Occult Lesion Localization for Gynecologic Tumor Relapses: Development of a Technique.

Radioguided Occult Lesion Localization for Gynecologic Tumor Relapses: Development of a Technique.

Journal: Clinical nuclear medicine

Published: May 11, 2023

Showing 1-12 of 39

Last Updated: 09/26/2026